vs

Side-by-side financial comparison of Bloom Energy Corp (BE) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

Bloom Energy Corp is the larger business by last-quarter revenue ($751.1M vs $487.7M, roughly 1.5× CLOVER HEALTH INVESTMENTS, CORP.). Bloom Energy Corp runs the higher net margin — 9.4% vs -10.1%, a 19.5% gap on every dollar of revenue. On growth, Bloom Energy Corp posted the faster year-over-year revenue change (130.4% vs 44.7%). Over the past eight quarters, Bloom Energy Corp's revenue compounded faster (51.7% CAGR vs 18.6%).

KR Sridhar is an Indian American engineer, inventor, professor, and entrepreneur. He is the founder, chairman, and chief executive officer (CEO) of Bloom Energy. Prior, Sridhar was a professor of Aerospace and Mechanical Engineering and the Director of the Space Technologies Laboratory (STL) at the University of Arizona. He worked with and advised NASA, and is a member of the National Academy of Engineering.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

BE vs CLOV — Head-to-Head

Bigger by revenue
BE
BE
1.5× larger
BE
$751.1M
$487.7M
CLOV
Growing faster (revenue YoY)
BE
BE
+85.6% gap
BE
130.4%
44.7%
CLOV
Higher net margin
BE
BE
19.5% more per $
BE
9.4%
-10.1%
CLOV
Faster 2-yr revenue CAGR
BE
BE
Annualised
BE
51.7%
18.6%
CLOV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BE
BE
CLOV
CLOV
Revenue
$751.1M
$487.7M
Net Profit
$70.7M
$-49.3M
Gross Margin
30.0%
Operating Margin
17.3%
-10.1%
Net Margin
9.4%
-10.1%
Revenue YoY
130.4%
44.7%
Net Profit YoY
-123.2%
EPS (diluted)
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BE
BE
CLOV
CLOV
Q1 26
$751.1M
Q4 25
$772.8M
$487.7M
Q3 25
$513.3M
$496.6M
Q2 25
$396.3M
$477.6M
Q1 25
$319.3M
$462.3M
Q4 24
$567.0M
$337.0M
Q3 24
$321.8M
$331.0M
Q2 24
$326.5M
$356.3M
Net Profit
BE
BE
CLOV
CLOV
Q1 26
$70.7M
Q4 25
$1.4M
$-49.3M
Q3 25
$-23.0M
$-24.4M
Q2 25
$-42.2M
$-10.6M
Q1 25
$-23.4M
$-1.3M
Q4 24
$105.2M
$-22.1M
Q3 24
$-14.6M
$-9.2M
Q2 24
$-61.2M
$7.4M
Gross Margin
BE
BE
CLOV
CLOV
Q1 26
30.0%
Q4 25
31.0%
Q3 25
29.5%
Q2 25
27.0%
Q1 25
27.8%
Q4 24
38.7%
Q3 24
24.5%
24.5%
Q2 24
21.0%
30.3%
Operating Margin
BE
BE
CLOV
CLOV
Q1 26
17.3%
Q4 25
11.3%
-10.1%
Q3 25
1.5%
-4.9%
Q2 25
-0.9%
-2.2%
Q1 25
-6.0%
-0.3%
Q4 24
18.5%
-6.4%
Q3 24
-3.0%
-2.7%
Q2 24
-7.1%
2.0%
Net Margin
BE
BE
CLOV
CLOV
Q1 26
9.4%
Q4 25
0.2%
-10.1%
Q3 25
-4.5%
-4.9%
Q2 25
-10.6%
-2.2%
Q1 25
-7.3%
-0.3%
Q4 24
18.5%
-6.6%
Q3 24
-4.5%
-2.8%
Q2 24
-18.7%
2.1%
EPS (diluted)
BE
BE
CLOV
CLOV
Q1 26
$0.44
Q4 25
$99.91
Q3 25
$-100.00
Q2 25
$-0.18
Q1 25
$-0.10
Q4 24
$0.45
Q3 24
$-0.06
Q2 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BE
BE
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$78.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$948.0K
$308.7M
Total Assets
$4.7B
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BE
BE
CLOV
CLOV
Q1 26
Q4 25
$2.5B
$78.3M
Q3 25
$595.1M
Q2 25
$574.8M
Q1 25
$794.8M
Q4 24
$802.9M
$194.5M
Q3 24
$495.7M
$288.0M
Q2 24
$581.7M
$254.8M
Total Debt
BE
BE
CLOV
CLOV
Q1 26
Q4 25
$2.6B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
BE
BE
CLOV
CLOV
Q1 26
$948.0K
Q4 25
$768.6M
$308.7M
Q3 25
$653.1M
$340.9M
Q2 25
$594.6M
$344.2M
Q1 25
$578.3M
$336.1M
Q4 24
$562.5M
$341.1M
Q3 24
$430.9M
$342.2M
Q2 24
$423.3M
$324.9M
Total Assets
BE
BE
CLOV
CLOV
Q1 26
$4.7B
Q4 25
$4.4B
$541.0M
Q3 25
$2.6B
$559.7M
Q2 25
$2.5B
$575.0M
Q1 25
$2.6B
$583.7M
Q4 24
$2.7B
$580.7M
Q3 24
$2.6B
$653.0M
Q2 24
$2.5B
$674.2M
Debt / Equity
BE
BE
CLOV
CLOV
Q1 26
Q4 25
3.41×
Q3 25
1.73×
Q2 25
1.91×
Q1 25
1.96×
Q4 24
2.01×
Q3 24
2.62×
Q2 24
2.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BE
BE
CLOV
CLOV
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BE
BE
CLOV
CLOV
Q1 26
Q4 25
$418.1M
$-66.9M
Q3 25
$19.7M
$12.1M
Q2 25
$-213.1M
$5.4M
Q1 25
$-110.7M
$-16.3M
Q4 24
$484.2M
$34.8M
Q3 24
$-69.5M
$50.0M
Q2 24
$-175.5M
$44.8M
Free Cash Flow
BE
BE
CLOV
CLOV
Q1 26
Q4 25
$395.1M
$-69.0M
Q3 25
$7.4M
$11.4M
Q2 25
$-220.4M
$4.8M
Q1 25
$-124.9M
$-16.5M
Q4 24
$473.1M
$33.3M
Q3 24
$-83.8M
$49.6M
Q2 24
$-187.5M
$44.4M
FCF Margin
BE
BE
CLOV
CLOV
Q1 26
Q4 25
51.1%
-14.1%
Q3 25
1.4%
2.3%
Q2 25
-55.6%
1.0%
Q1 25
-39.1%
-3.6%
Q4 24
83.4%
9.9%
Q3 24
-26.0%
15.0%
Q2 24
-57.4%
12.5%
Capex Intensity
BE
BE
CLOV
CLOV
Q1 26
Q4 25
3.0%
0.4%
Q3 25
2.4%
0.1%
Q2 25
1.8%
0.1%
Q1 25
4.5%
0.0%
Q4 24
2.0%
0.5%
Q3 24
4.4%
0.1%
Q2 24
3.7%
0.1%
Cash Conversion
BE
BE
CLOV
CLOV
Q1 26
Q4 25
293.18×
Q3 25
Q2 25
Q1 25
Q4 24
4.60×
Q3 24
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BE
BE

Product$653.3M87%
Service$61.9M8%
Installation$25.9M3%
Electricity$9.9M1%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons